American Cancer Society National Conference on Purchasing Oncology Services : Current Methods and Models in the Marketplace. Chicago, IL, USA, 1997/09/11.
Members of the oncology community, rich in data from years of published clinical research, epidemiology, and tumor registry information, expect businesses to evaluate the quality of cancer care using classic scientific methods.
However, businesses lack sophistication in these data and tend to use significantly different criteria relating to cost, service, and access.
Logistical problems also abound, such as the wide variety of cancers, small sample sizes, and the frequency with which patients change insurance plans.
Adapting an approach first proposed by Donabedian employing criteria that can be measured, easily gathered, and whose presence/absence can be interpreted as having a consequence for patient care, the author proposes a system of evaluating cancer health care benefits.
Recognizing that classic outcomes analysis is too complex and inappropriate for business, companies and oncology providers maybe able to develop obtainable measures whose presence or absence has intuitive and documented relation to the quality of cancer care.
Mots-clés Pascal : Assurance maladie, Etats Unis, Amérique du Nord, Amérique, Analyse coût, Economie santé, Service hospitalier, Spécialité médicale, Cancérologie, Evaluation performance, Qualité, Soin, Analyse avantage coût
Mots-clés Pascal anglais : Health insurance, United States, North America, America, Cost analysis, Health economy, Hospital ward, Medical specialty, Cancerology, Performance evaluation, Quality, Care, Cost benefit analysis
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0295852
Code Inist : 002B30A01B. Création : 27/11/1998.